Research

Feasibility Study of Human Umbilical Cord Tissue Derived Mesenchymal Stem Cells in Patients with MS

Mesenchymal cells from umbilical cord express preferentially secreted factors for neurogenesis, angiogenesis and neuroprotection

Int. J. Mol. Sci. 2013, 14, 17986-18001; doi:10.3390/ijms140917986

Wharton Jelly Clinical Trials

Mesenchymal stem cells clinical trials

Stem cell infusions for heart disease

Stem Cell Infusions for Crohn’s Disease

Biogenix research

 
FDA Statement Concerning Treatments
 The use of STEM CELL treatments are NOT FDA approved. Even though these treatments are investigational, highly promising and significant results have been documented.  Because randomized, double-blinded studies have not been completed, STEM CELL treatments should be considered investigational. As with all treatments, results meeting your expectations cannot be guaranteed.
Close Menu